BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khaliq S, Raza SM. Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan. Medicina (Kaunas) 2018;54:E80. [PMID: 30400604 DOI: 10.3390/medicina54050080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen TK, Van Le D. Identification of NS5B Resistance-Associated Mutations in Hepatitis C Virus Circulating in Treatment Naïve Vietnamese Patients. IDR 2022;Volume 15:1547-54. [DOI: 10.2147/idr.s353605] [Reference Citation Analysis]
2 Li C, Liang J, Xiang H, Chen H, Tian J. Effectiveness of direct-acting antivirals in maintenance hemodialysis patients complicated with chronic hepatitis C. Medicine (Baltimore) 2020;99:e23384. [PMID: 33235113 DOI: 10.1097/MD.0000000000023384] [Reference Citation Analysis]
3 Abd Ellah NH, Tawfeek HM, John J, Hetta HF. Nanomedicine as a future therapeutic approach for Hepatitis C virus. Nanomedicine (Lond) 2019;14:1471-91. [PMID: 31166139 DOI: 10.2217/nnm-2018-0348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
4 Butt N, Muhammad I, Abou Bakr A, Akhtar Z, Ali M, Syed Muhammad S, Maheshwary N. Efficacy and Safety of Sofosbuvir-Velpatasvir combination in Hepatitis C Virus-infected Pakistani Patients without Cirrhosis or with Compensated Cirrhosis: A Prospective, Open-label Interventional Trial. Cureus 2020;12:e6537. [PMID: 32042516 DOI: 10.7759/cureus.6537] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Hashmi ZY, Zia MQ, Bajwa A, Ahmed M, Anwer N, Raza M, Baqar JB. New drugs and new concerns: Gaining insight through Pharmacovigilance of direct acting Anti-Viral's in chronic HCV patients. Pak J Med Sci 2021;37:299-304. [PMID: 33679903 DOI: 10.12669/pjms.37.2.3400] [Reference Citation Analysis]
6 Sarhan M, El-Bitar AMH, Hotta H. Potent virucidal activity of honeybee "Apis mellifera" venom against Hepatitis C Virus. Toxicon 2020;188:55-64. [PMID: 33068557 DOI: 10.1016/j.toxicon.2020.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Scelza G, Amato A, Pagano AM, Matteis G, Caruso R, Scelza A, Sisalli L, Biasi S, Marigliano F, Gagliardi M, Martina S, Iandolo A. Effect of hepatitis C antiviral therapy on oral lichen planus and hyposalivation in inmates. Ann Gastroenterol 2022;35:74-9. [PMID: 34987292 DOI: 10.20524/aog.2021.0672] [Reference Citation Analysis]
8 Armandi A, Caviglia GP, Saracco GM, De Marco L, Fagoonee S, Pellicano R. Seronegative occult hepatitis C virus infection: what is its clinical relevance? Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02637-3] [Reference Citation Analysis]
9 Suciu A, Abenavoli L, Pellicano R, Luzza F, Dumitrascu DL. Transaminases: oldies but goldies. A narrative review. Minerva Gastroenterol Dietol 2020;66:246-51. [PMID: 31994373 DOI: 10.23736/S1121-421X.20.02660-4] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Riaz S, Tiwana H, Adil M, Ali K, Javed T. Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytes. Arch Microbiol 2022;204. [DOI: 10.1007/s00203-021-02646-3] [Reference Citation Analysis]
11 Ahmed S, Ayub M, Naeem M, Nazir FH, Hussain A, Ghilzai D, Magnius LO, Sajjad A, Norder H. Thalassemia Patients from Baluchistan in Pakistan Are Infected with Multiple Hepatitis B or C Virus Strains. Am J Trop Med Hyg 2021:tpmd200740. [PMID: 33534738 DOI: 10.4269/ajtmh.20-0740] [Reference Citation Analysis]
12 Janahi EM, Parkar SFD, Mustafa S, Eisa ZM. Implications of Hepatitis E Virus in Blood Transfusions, Hemodialysis, and Solid Organ Transplants. Medicina (Kaunas) 2020;56:E206. [PMID: 32344807 DOI: 10.3390/medicina56050206] [Reference Citation Analysis]
13 Lim AG, Walker JG, Mafirakureva N, Khalid GG, Qureshi H, Mahmood H, Trickey A, Fraser H, Aslam K, Falq G, Fortas C, Zahid H, Naveed A, Auat R, Saeed Q, Davies CF, Mukandavire C, Glass N, Maman D, Martin NK, Hickman M, May MT, Hamid S, Loarec A, Averhoff F, Vickerman P. Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. Lancet Glob Health 2020;8:e440-50. [PMID: 32087176 DOI: 10.1016/S2214-109X(20)30003-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]